Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
Mocetinostat and clofarabine offer valuable insights for the development of novel targeted therapies in neuroblastoma.
Authors
- Longlong Xie (ORCID: https://orcid.org/0000-0002-5690-9083)
- Zhenghui Xiao (ORCID: https://orcid.org/0000-0001-6308-9688)
- Ming Li (ORCID: https://orcid.org/0000-0001-6291-9328)
- Yong Li (ORCID: https://orcid.org/0000-0001-6266-8717)
- Zan Liu (ORCID: https://orcid.org/0000-0002-2356-017X)
- Zitong Zhao (ORCID: https://orcid.org/0000-0001-9279-0924)
- Ting Luo
Institutions
- Central South University (CN)
- Changsha Medical University (CN)
- Hunan Normal University (CN)
- Hunan Children's Hospital (CN)
- Changsha Hospital for Maternal and Child Health Care (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2025-02-26
- DOI
- https://doi.org/10.1186/s12967-025-06298-5
- Citations
- 21
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 29.17
Funders
- Health Commission of Hunan Province
- Natural Science Foundation of Hunan Province